Wire Stories
-
608Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) has committed US $60 million in sequencing capabilities to a global pathogen genomics initiative, in partnership...
-
668
OnMicro Launches Four Families of RF Switches
New 5G Tx, Antenna Tuner, Antenna and WiFi Switches Combine Industry-Leading Performance with Common Pinout HONG KONG–(BUSINESS WIRE)–OnMicro, an innovator in RF...
-
677
Join the Hunt! Monster Hunter Rise and Ninjala Collab Starts Today
Players can don their favorite armor, grill up monster meat, and transform into some cuddly companions TOKYO–(BUSINESS WIRE)–Get ready to swing into...
-
591
PlayCroco Online Casino Bring the Heat With Wild Fire 7s
Scorching new online pokie roars onto popular online casino SYDNEY–(BUSINESS WIRE)–It�s time to fire up PlayCroco because a red-hot pokie is about...
-
558
First Insight and Luxury Connect Expand Partnership
GURUGRAM, India & PITTSBURGH–(BUSINESS WIRE)–First Insight, Inc., the world�s leading technology company that is transforming how companies make product investment, pricing and...
-
606
China Sevoflurane Investigation Market Report 2021-2025 Featuring Shanghai Hengrui Pharma, Maruishi Pharma, Lunan Pharma Group, Baxter Healthcare, & Hebei Yipin Pharma – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Sevoflurane Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Sevoflurane is an inhalation general anesthetic...
-
679
Boyd Corporation Recognized for Corporate Social Responsibility Efforts for 2nd Consecutive Year
Boyd Receives Sustainable Development Programme Gold Award from Deutsche Telekom for Recognition of Outstanding Achievement in Corporate Social Responsibility, Improving Upon 2020�s...
-
683
BRUKINSA� (Zanubrutinib) Demonstrates Superior Objective Response Rate by Investigator Assessment and Reduced Rates of Atrial Fibrillation or Flutter at Interim Analysis in Head-to-Head Trial Against Ibrutinib in Chronic Lymphocytic Leukemia
CAMBRIDGE, Mass. & BEIJING–(BUSINESS WIRE)–BeiGene (NASDAQ: BGNE; HKEX: 06160) announced positive results from a planned interim analysis of the Phase 3 ALPINE...
-
542
China Dezocine Market Investigation Report 2021: Sales of Dezocine had a Growth Trend from 2016 to 2019 – Forecast to 2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Dezocine Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Dezocine is an opioid analgesic that...
-
542
ZYUS Life Sciences Increases Global Patient Access to Medical Cannabinoids in Australia with Health House International Sales and Distribution Agreement
New agreement will enable patients in Australia to access ZYUS� cannabinoid formulations as part of international expansion SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences...
